OTC · Biotechnology

E-therapeutics Plc (ETXPF) Stock

$0.13 +0.00% OTC: ETXPF Healthcare

E-therapeutics Plc is a UK-based company focused on drug discovery. The core of its work involves a sophisticated computational platform that employs in-silico screening and unique network models to identify and predict which compounds or biological targets can effectively alter relevant biological processes.

Valuation

MetricValue
Price$0.13
Market Cap$75.96M
P/E Ratio-4.71
P/B Ratio2.39
P/S Ratio177.32
EPS (TTM)$-0.02
52-Week High$0.13
52-Week Low$0.13
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-40.58%
ROA-44.72%
ROCE-61.83%
Gross Margin100.00%
Operating Margin—
Net Margin—
Debt/Equity0.03
Current Ratio8.87

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$1.0M$0$0$0
Operating Profit$-6.0M$-13.0M$-10.0M$-14.0M$-19.0M
Net Profit$-5.0M$-11.0M$-8.0M$-11.0M$-15.0M
EPS$-0.01$-0.02$-0.02$-0.02$-0.02
Op Margin-1405.4%-2000.4%-2155.6%-4337.7%—

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$20.0M$40.0M$35.0M$25.0M$38.0M
Total Liabilities$1.0M$2.0M$2.0M$3.0M$2.0M
Cash$18.0M$15.0M$32.0M$21.0M$21.0M
Borrowings$0$1.0M$0$1.0M$0

Latest News

Hyundai Motor reports 21% drop in Q2 operating profit, misses forecasts Reuters · Jul 23, 2026 Asian stocks rise as AI capex ramps up, oil at six-week highs Reuters · Jul 23, 2026 TenPay Global Named to CNBC's World's Top Fintech Companies 2026 List PR Newswire · Jul 23, 2026 Besi posts sharp rise in quarterly orders Reuters · Jul 23, 2026 Nokia provides recast comparative financial information reflecting the presentation of Fixed Wireless Access CPE and Enterprise Campus Edge businesses as discontinued operations GlobeNewswire · Jul 23, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-5.0M$-10.0M$-8.0M$-11.0M$-17.0M
Investing Cash Flow$-5.0M$-25.0M$18.0M$0$-13.0M
Financing Cash Flow$0$8.0M$0$0$29.0M
Net Cash Flow$13.0M$-3.0M$20.0M$-11.0M$0
Free Cash Flow$-5.0M$-12.0M$-8.0M$-11.0M$-17.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.05
EV / EBITDA-2.65
FCF Yield-19.76%
Quick Ratio8.87
Interest Coverage—
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $340.97 +1.29% 38.93 $5.01T 0.32%
MSFTMicrosoft Corporation $541.15 +1.14% 28.68 $4.02T 0.76%
GOOGLAlphabet Inc. $352.72 +0.30% 16.94 $4.27T 0.26%
AMZNAmazon.com, Inc. $259.53 -1.11% 19.82 $2.79T 0.00%
METAMeta Platforms, Inc. $742.96 +3.38% 27.93 $1.89T 0.28%

About E-therapeutics Plc

E-therapeutics Plc is a UK-based company focused on drug discovery. The core of its work involves a sophisticated computational platform that employs in-silico screening and unique network models to identify and predict which compounds or biological targets can effectively alter relevant biological processes. Furthermore, the company is advancing an RNA interference (RNAi) platform designed for highly specific gene silencing. Founded in 2001, E-therapeutics Plc operates from its headquarters in London, United Kingdom.

E-therapeutics Plc is headquartered in GB.

E-therapeutics Plc (ETXPF) stock trades at $0.13 with a market capitalization of $75.96M. The stock is valued at a negative price-to-earnings (P/E) ratio of -4.71, reflecting a net loss over the last twelve months, price-to-book of 2.39, price-to-sales of 177.32. Over the past 52 weeks the stock has ranged between $0.13 and $0.13, and currently trades at or near its 52-week high.

On profitability, E-therapeutics Plc generates a return on equity (ROE) of -40.58% (negative, reflecting a net loss), return on capital employed of -61.83%.

Official website: www.etherapeutics.co.uk

Related Healthcare Stocks

LLY Eli Lilly and Company $1182.62 +0.28% JNJ Johnson & Johnson $263.73 +0.88% ABBV AbbVie Inc. $281.04 +1.65% MRK Merck & Company, Inc. Common Stock (new) $145.45 -0.10% UNH UnitedHealth Group Incorporated Common Stock (DE) $378.52 -0.21% NVS Novartis AG $143.84 +0.06% AZN AstraZeneca PLC $158.33 -0.55% TMO Thermo Fisher Scientific Inc $662.24 +0.64% AMGN Amgen Inc. $417.57 +0.65% GILD Gilead Sciences, Inc. $150.43 -0.49% ABT Abbott Laboratories $101.82 +2.23% NVO Novo Nordisk A/S $38.58 -0.16%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.